Estimated additional performance shares (in dollars per share)

[Table of Contents](#ic55317410763413da1d4be4008f977bd_658)Globe Life Inc.Notes to Consolidated Financial Statements(Dollar amounts in thousands, except per share data)An analysis of nonvested restricted stock is as follows:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | ExecutiveRestrictedStock |  | ExecutivePerformanceShares |  | DirectorsRestrictedStock |  | DirectorsRestrictedStockUnits |  | Total |
| 2019: |  |  |  |  |  |  |  |  |  |
| Balance at December 31, 2018 | 12,000  |  |  | 752,629  |  |  | —  |  |  | —  |  |  | 764,629  |  |
| Grants | —  |  |  | 156,500  |  |  | 8,840  |  |  | 6,634  |  |  | 171,974  |  |
| Additional performance shares(1) | —  |  |  | 118,812  |  |  | —  |  |  | —  |  |  | 118,812  |  |
| Restriction lapses | (12,000) |  |  | (311,399) |  |  | (8,840) |  |  | (6,634) |  |  | (338,873) |  |
| Forfeitures | —  |  |  | —  |  |  | —  |  |  | —  |  |  | —  |  |
| Balance at December 31, 2019 | —  |  |  | 716,542  |  |  | —  |  |  | —  |  |  | 716,542  |  |
| 2020: |  |  |  |  |  |  |  |  |  |
| Grants | —  |  |  | 151,200  |  |  | 4,548  |  |  | 6,161  |  |  | 161,909  |  |
| Additional performance shares(1) | —  |  |  | (65,473) |  |  | —  |  |  | —  |  |  | (65,473) |  |
| Restriction lapses | —  |  |  | (271,843) |  |  | (4,548) |  |  | (6,161) |  |  | (282,552) |  |
| Forfeitures | —  |  |  | (11,450) |  |  | —  |  |  | —  |  |  | (11,450) |  |
| Balance at December 31, 2020 | —  |  |  | 518,976  |  |  | —  |  |  | —  |  |  | 518,976  |  |
| 2021: |  |  |  |  |  |  |  |  |  |
| Grants | —  |  |  | 139,500  |  |  | 10,031  |  |  | 7,258  |  |  | 156,789  |  |
| Additional performance shares(1) | —  |  |  | (94,883) |  |  | —  |  |  | —  |  |  | (94,883) |  |
| Restriction lapses | —  |  |  | (210,155) |  |  | (9,742) |  |  | (6,969) |  |  | (226,866) |  |
| Forfeitures | —  |  |  | (11,050) |  |  | —  |  |  | —  |  |  | (11,050) |  |
| Balance at December 31, 2021 | —  |  |  | 342,388  |  |  | 289  |  |  | 289  |  |  | 342,966  |  |

(1)Estimated additional (reduced) share grants expected due to achievement of performance criteria.  
An analysis of the weighted-average grant-date fair values per share of nonvested restricted stock is as follows for the year 2021:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Executive Restricted Stock |  | Executive Performance Shares |  | Directors Restricted Stock |  | Directors Restricted Stock Units |
| Grant-date fair value per share at January 1, 2021  | $ | —  |  |  | $ | 90.13  |  |  | $ | —  |  |  | $ | —  |  |
| Grants | —  |  |  | 98.32  |  |  | 92.40  |  |  | 92.41  |  |
| Estimated additional performance shares | —  |  |  | (91.43) |  |  | —  |  |  | —  |  |
| Restriction lapses | —  |  |  | (87.60) |  |  | (92.40) |  |  | (92.41) |  |
| Forfeitures | —  |  |  | (87.60) |  |  | —  |  |  | —  |  |
| Grant-date fair value per share at December 31, 2021  | —  |  |  | 94.75  |  |  | 92.56  |  |  | 92.56  |  |

  
111 GL 2021 FORM 10-K
